USL311

CAS No. 1373268-67-7

USL311( —— )

Catalog No. M22471 CAS No. 1373268-67-7

USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4.?USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 106 In Stock
5MG 178 In Stock
10MG 259 In Stock
25MG 434 In Stock
50MG 627 In Stock
100MG 893 In Stock
500MG 1782 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    USL311
  • Note
    Research use only, not for human use.
  • Brief Description
    USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4.?USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.
  • Description
    USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4.?USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    CXCR
  • Recptor
    CXCR4
  • Research Area
    Cancer
  • Indication
    Solid Tumors (Phase 1)Relapsed/Recurrent GBM (Phase 2)

Chemical Information

  • CAS Number
    1373268-67-7
  • Formula Weight
    422.57
  • Molecular Formula
    C24H34N6O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:24 mg/mL (59.79 mM; Need ultrasonic)
  • SMILES
    CC(C)N1CCC(CC1)N1CCCN(CC1)c1cccc(n1)C(=O)Nc1ccncc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Peter Richardson. Usl-311 for use in the treatment of cancer. WO2018162924A1
molnova catalog
related products
  • NUCC-390

    NUCC-390, a novel small-molecule CXCR4 receptor agonist, selectively induces CXCR4 receptor internalization while acting antagonistically to AMD3100.

  • AMG 487

    AMG 487 prevents the chemokines I-IP-10 and I-ITAC from binding to CXCR3.?In the cellular assays, AMG 487 inhibits CXCR3-mediated cell migration with IC50 values of 8nM, 15nM and 36nM for I-IP-10, I-ITAC and MIG, respectively.

  • Ajmaline

    Ajmaline is a class Ia anti-arrhythmic compound that is widely used for the diagnosis of Brugada syndrome and the acute treatment of atrial or ventricular tachycardia.